Diagnostic Approach to Mastitis in Dairy Cows: Pathogen Identification and Herd Patterns

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Differentiating between clinical mastitis (visible milk/udder abnormalities) and subclinical mastitis (elevated somatic cell count without visible changes) is fundamental, guiding the choice between rapid individual case diagnostics and broader herd-level investigations.
• Pathogen classification into contagious (Staphylococcus aureus, Streptococcus agalactiae, Mycoplasma bovis) and environmental (Escherichia coli, Streptococcus uberis) dictates sampling strategy: contagious pathogens require individual quarter/cow sampling, while environmental pathogens necessitate repeated sampling to identify herd patterns.
• Conventional bacteriological culture remains the reference standard for pathogen identification and antimicrobial susceptibility testing, but requires 24-48 hours; PCR offers rapid detection (hours) and can identify non-viable organisms or fastidious pathogens like Mycoplasma species, but lacks susceptibility data.
• Herd-level investigations are triggered by increased clinical mastitis incidence (>25 cases/100 cow-years) or elevated bulk tank somatic cell counts (>200,000 cells/mL), focusing on identifying transmission dynamics through longitudinal data analysis and bulk tank cultures for contagious pathogen surveillance.
• Mycoplasma bovis requires specialized diagnostic approaches (specific culture or PCR) due to its therapy resistance and rapid spread, with control heavily reliant on early detection and culling of infected animals rather than treatment.
• Accurate interpretation of diagnostic results necessitates integration with clinical signs, somatic cell count data, and herd history, recognizing limitations such as the inability of in vitro susceptibility testing to always predict intramammary cure for certain pathogens.

Mastitis remains the most economically damaging infectious disease of dairy cattle, combining losses from reduced milk production, premature culling, treatment costs, and compromised animal welfare. The diagnostic challenge facing the practitioner is not simply identifying that inflammation exists, but determining which pathogen is responsible, whether the pattern of infection reflects contagious or environmental transmission, and which diagnostic tools will yield actionable answers within the constraints of farm economics and laboratory access. This article provides a structured diagnostic framework for clinical and subclinical mastitis, covering sample collection, culture and sensitivity testing, molecular diagnostics, and herd-level pattern interpretation. It is written for practicing veterinarians who must integrate laboratory results with on-farm observations to guide control decisions.

The distinction between diagnosing an individual case and diagnosing a herd problem is central to mastitis work. An individual clinical case requires rapid pathogen identification to inform therapy selection and prognosis. A herd investigation requires repeated sampling, bulk tank analysis, and longitudinal interpretation to identify transmission dynamics and reservoir sources. Both approaches share core laboratory techniques, but they differ in sampling strategy, sample volume, and the questions asked of the data. This article addresses both scales of investigation and clarifies when each is appropriate.

At a Glance

Pathobiology of Intramammary Infection

Mastitis is inflammation of the mammary parenchyma, most commonly initiated by bacterial invasion of the teat canal and ascent into the gland cistern. The host response determines the clinical presentation. Gram-negative organizms such as mammary pathogenic E. coli trigger rapid recruitment of neutrophils and release of proinflammatory mediators, producing acute clinical disease that can range from mild milk changes to severe systemic collapse. Gram-positive pathogens often establish more chronic infections, with bacterial adhesion to mammary epithelium and biofilm formation contributing to persistence. The association between specific E. coli virulence factors and disease severity remains incompletely characterized, which complicates attempts to predict clinical outcome from pathogen genotype alone Goulart and Mellata, Escherichia coli Mastitis in Dairy Cattle.

The classification of mastitis pathogens into contagious and environmental categories shapes diagnostic strategy. Contagious pathogens, including S. aureus, S. agalactiae, and Mycoplasma bovis, are transmitted primarily during milking, with the milking machine and milkers' hands serving as vectors. Environmental pathogens, including coliforms and environmental streptococci, are acquired from bedding, manure, and soil between milkings. This distinction matters because the diagnostic sampling strategy differs: contagious pathogens are best detected by culturing individual quarters or composite samples from multiple cows, while environmental pathogens may appear sporadically and require repeated sampling to establish a herd pattern. M. bovis deserves particular attention because it causes therapy-resistant mastitis that spreads rapidly within large dairy herds, and control depends on early detection and culling of infected animals instead of treatment Pfützner and Sachse, Mycoplasma bovis as an agent of mastitis.

Diagnostic Techniques and Their Principles

Conventional Bacteriological Culture

Aseptic collection of milk from the affected quarter into a sterile vial remains the reference standard for pathogen identification. The sample must be collected before antimicrobial administration, because even a single dose can suppress bacterial growth and produce false-negative cultures. Samples should be refrigerated and transported to the laboratory within 24 to 48 hours. Freezing is generally avoided for culture samples because it reduces bacterial viability, although it is acceptable for samples destined for PCR testing.

Culture on blood agar and MacConkey agar, with incubation for 24 to 48 hours, identifies the majority of common mastitis pathogens. Gram stain, catalase test, and coagulase testing differentiate staphylococci from streptococci and further speciate isolates. The principal limitation of culture is time: a minimum of 24 hours is required for preliminary identification, and antimicrobial susceptibility testing adds another 24 hours. For acutely ill cows, treatment decisions often must be made before culture results are available, which reduces the practical utility of culture for individual case management.

Molecular Diagnostics

Polymerase chain reaction (PCR) assays detect bacterial DNA directly from milk, eliminating the need for viable organizms and reducing turnaround time to several hours. Multiplex PCR panels can simultaneously detect the major mastitis pathogens, including E. coli, S. aureus, S. agalactiae, S. dysgalactiae, and S. uberis, with detection limits compatible with clinical diagnosis Riffon et al., rapid and sensitive PCR test for mastitis pathogens. PCR is particularly valuable when samples have been frozen, when cows have received recent antimicrobial therapy, or when fastidious organizms such as Mycoplasma species are suspected.

PCR does not provide antimicrobial susceptibility data, and it cannot distinguish viable from nonviable organizms. A positive PCR result in a cow that has cleared the infection may lead to unnecessary treatment. Conversely, PCR may detect organizms present in low numbers that culture would miss, which can complicate interpretation when multiple pathogens are detected in a single sample. The practitioner must interpret PCR results in the context of clinical signs and somatic cell count data instead of treating every positive result as an active infection.

Somatic Cell Count and California Mastitis Test

The somatic cell count (SCC) is an indirect measure of intramammary inflammation, primarily reflecting neutrophil influx. Individual cow SCC is used for subclinical mastitis monitoring, with thresholds for abnormal milk defined by regulatory bodies and milk quality programs. The California Mastitis Test (CMT) provides a semiquantitative estimate of SCC at the cow side, using a reagent that causes DNA to gel in proportion to cell numbers. CMT is most useful for screening individual quarters to identify which glands require sampling for culture. Neither SCC nor CMT identifies the causative pathogen, and both are influenced by stage of lactation, age, and concurrent disease.

Sampling Strategy by Clinical Scenario

Acute Clinical Mastitis

For a cow with acute clinical mastitis, collect a single aseptic milk sample from the affected quarter before administering any antimicrobial. If the cow is systemically ill, treatment should not be delayed pending culture results, but the sample should still be collected first. Submit the sample for culture and susceptibility testing, recognizing that the results will guide therapy for the remainder of the treatment course and will inform prognosis. PCR may be preferred when rapid identification is needed, particularly if the herd has a history of Mycoplasma mastitis or if the cow has failed to respond to initial therapy.

Subclinical Mastitis and Herd Investigations

Subclinical mastitis is detected through SCC monitoring, either from individual cow records or from CMT screening of quarters. When a herd investigation is warranted, collect composite milk samples from a representative sample of cows with elevated SCC, typically 10 to 20 cows, and submit them for culture. Bulk tank culture provides a herd-level overview and is useful for detecting contagious pathogens such as S. agalactiae and M. bovis, but it cannot identify individual infected cows. A negative bulk tank culture does not rule out contagious mastitis, particularly when the prevalence of infection is low.

Diagnostic Sequence for the Individual Cow

The diagnostic approach begins with a complete history: days in milk, parity, previous mastitis episodes, recent calving events, and any treatments already administered. A cow that has received antibiotics within the preceding 14 days may yield false-negative culture results, so record treatment timing before sampling. Physical examination should assess rectal temperature, heart rate, rumen fill, hydration status, and udder symmetry. The California Mastitis Test provides a rapid, cow-side estimate of somatic cell count and is most informative when interpreted alongside culture results instead of as a standalone test.

For clinical mastitis, collect the milk sample before administering any therapy. The affected quarter should be identified, the teat end cleaned with an alcohol pledget, and the first streams of milk discarded. Collect 5 to 10 mL into a sterile tube using aseptic technique. If the cow has been treated recently, note this on the submission form so the laboratory can adjust interpretation. For subclinical mastitis, sample all four quarters individually, composite samples obscure within-udder patterns and can dilute a high-count quarter below the detection threshold.

The decision to culture an individual clinical case depends on severity and recurrence. Mild cases with normal systemic parameters and no previous episodes may be managed without culture, but any cow with fever, anorexia, or a swollen quarter warrants sampling. Recurrent clinical episodes in the same quarter, or cases that fail to respond to initial therapy, should always be cultured. The MSD Veterinary Manual provides the standard framework for classifying mastitis severity and matching sampling intensity to clinical presentation.

Interpretation of Culture and Susceptibility Results

Culture results must be interpreted in context. A pure growth of a recognized pathogen such as Staphylococcus aureus or Streptococcus agalactiae is diagnostically meaningful at any colony count. Environmental organizms such as Escherichia coli or Streptococcus uberis may be present as contaminants, so growth of these organizms from a single quarter should be interpreted cautiously unless the cow has clinical signs consistent with the isolate. No growth after 48 hours does not exclude infection, slow-growing organizms such as Mycoplasma bovis require specialised media and extended incubation, and the review of Mycoplasma bovis as an agent of mastitis notes that routine culture will miss this pathogen entirely.

Antimicrobial susceptibility testing is most valuable for gram-positive pathogens, where resistance patterns vary between herds and over time. For gram-negative organizms such as E. coli, susceptibility testing has limited predictive value because clinical response depends more on host immune status and the severity of the inflammatory response than on the minimum inhibitory concentration of the drug. The discussion of E. coli mastitis diagnosis and treatment challenges emphasizes that antimicrobial resistance in mammary pathogenic E. coli is an increasing concern, but the clinical decision to treat a coliform mastitis case is rarely altered by susceptibility data.

Polymerase chain reaction (PCR) panels offer faster turnaround than culture, often within 24 hours, and can detect organizms that are fastidious or non-viable. The development of PCR-based identification of major mastitis pathogens demonstrated detection limits compatible with clinical diagnosis, and PCR has the advantage of detecting DNA from organizms that have been killed by prior therapy. The trade-off is that PCR cannot provide susceptibility data, and it may detect DNA from non-viable organizms that are not causing active infection. Choose PCR when speed is critical, such as in a severe clinical case where treatment decisions must be made immediately, or when the herd history suggests a pathogen that is difficult to culture.

Herd-Level Pattern Recognition

The transition from individual cow diagnosis to herd investigation occurs when clinical mastitis incidence exceeds 25 cases per 100 cow-years, when bulk tank somatic cell count rises above 200,000 cells per mL, or when multiple cows present with the same clinical syndrome. The herd investigation begins with a review of the last 6 to 12 months of somatic cell count data, clinical mastitis records, and culling decisions. The goal is to identify whether the problem is predominantly contagious, environmental, or a mixture of both.

Contagious pathogens, including S. aureus, S. agalactiae, and Mycoplasma bovis, spread during milking and are associated with persistently elevated somatic cell counts, chronic infections, and a pattern of new infections appearing in cows milked after an infected animal. Environmental pathogens, including E. coli, S. uberis, and Klebsiella species, are associated with bedding contamination, wet conditions, and a pattern of clinical cases that cluster in specific pens or seasons. The comprehensive review of bovine mastitis management approaches notes that no single therapeutic strategy eliminates the causative agent when used alone, which reinforces the need for pattern-based control instead of case-by-case treatment.

Bulk tank culture is a useful screening tool for contagious pathogens. A bulk tank sample that is positive for S. agalactiae or Mycoplasma bovis indicates that the pathogen is present in the herd, although a negative bulk tank culture does not rule out a low prevalence of infection. Individual cow sampling should follow bulk tank screening to identify the infected animals. For Mycoplasma bovis, the review of diagnostic methods for this pathogen stresses that early detection is essential because antibiotic treatment is ineffective and control depends on culling infected animals.

Diagnostic Decision Tree

The following table links pathogen identification to herd-level pattern and directs the next diagnostic step.

Documentation and Monitoring

Every mastitis case should be recorded in a format that allows pattern analysis. The minimum dataset includes cow identification, affected quarter, date of onset, clinical severity score, culture result if performed, treatment administered, and outcome. This record allows the practitioner to calculate quarter-level cure rates, identify cows with recurrent infections, and monitor the effectiveness of control interventions. The FAO animal production and health guidance emphasizes that herd-level monitoring depends on consistent data collection at the farm level.

Bulk tank somatic cell count should be monitored monthly, and the trend over time is more informative than any single value. A rising bulk tank SCC suggests increasing prevalence of contagious infection, while a stable bulk tank SCC with frequent clinical cases suggests an environmental problem. Individual cow somatic cell count data from the milk recording service should be reviewed quarterly to identify cows with persistently elevated counts that may be chronic carriers.

The diagnostic workup is complete when the pathogen pattern is consistent with the herd history and the control measures address the identified transmission routes. If the pattern is unclear, repeat sampling after 2 to 4 weeks may be necessary, particularly if mycoplasma infection is suspected. The WOAH terrestrial animal health standards provide a framework for surveillance and reporting that can be adapted to herd-level mastitis monitoring, although the specific requirements vary by region and production system.

Recognized Failure Modes and Early Detection

The diagnostic process fails in predictable ways. The most consequential failure is sampling the wrong quarter or the wrong cow. A composite sample from a clinically normal quarter dilutes the pathogen concentration from an affected quarter and can produce a false negative. Collect quarter-level samples from any cow with visibly abnormal milk before treatment begins. A second common failure is freezing samples intended for culture. Freezing kills fastidious organizms, particularly Mycoplasma bovis, and distorts quantitative results. Refrigerate samples at 4°C and culture within 24 to 48 hours. If transport to a laboratory will exceed 48 hours, freeze only if mycoplasma testing is not required, and record that limitation on the submission form.

Contamination during collection produces misleading polymicrobial growth. The pre-dipping contact time, drying, and foremilk discard steps are not optional. When a sample yields three or more distinct colony types with no dominant organizm, recollect before interpreting the result. A single colony of a skin commensal such as Bacillus species does not establish infection.

Early detection of these failures depends on the laboratory report itself. A culture result that does not match the clinical presentation, for example a pure growth of Escherichia coli from a cow with chronic, high somatic cell count mastitis, should trigger a recollect instead of a treatment decision. The same applies when a sample from a clinically severe case returns no growth after 48 hours, consider mycoplasma, Prototheca, or yeast, all of which require extended incubation or special media.

Common Diagnostic Errors and Corrective Action

Less experienced clinicians often over-interpret antimicrobial susceptibility testing. In vitro susceptibility does not predict intramammary cure, particularly for Staphylococcus aureus and Streptococcus uberis, where host factors and biofilm formation determine outcome. The susceptibility panel guides antibiotic selection, but the decision to treat or cull a chronic cow rests on cow-level factors: age, parity, production, and previous response to therapy. The MSD Veterinary Manual provides the standard framework for interpreting culture and sensitivity in the context of the individual animal.

A second error is treating subclinical mastitis without culture. The distribution of pathogens in subclinical disease differs from clinical disease, and blanket therapy selects for resistance. Culture before treatment whenever the herd somatic cell count exceeds the target threshold. A third error is failing to distinguish new infections from chronic infections. Without sequential sampling, a persistently infected cow is misclassified as a new case, which inflates the apparent new infection rate and misdirects control efforts.

A fourth error is ignoring the milk sample quality. Samples collected from cows already treated with antibiotics, or from cows in early lactation with colostrum-like milk, may fail to grow organizms. Record treatment history on the submission form and interpret no-growth results accordingly.

Limitations of Current Evidence

The evidence base for mastitis diagnostics has genuine gaps. The association between specific E. coli virulence factors and clinical severity remains incompletely understood, which limits the prognostic value of identifying the pathogen to species level alone. A review of E. coli mastitis notes that antimicrobial resistance now spans all major antibiotic classes in mammary pathogenic strains, yet the clinical relevance of resistance phenotypes for treatment outcome is not fully resolved.

Expert opinion still differs on the role of routine mycoplasma screening. The early description of M. bovis as a cause of therapy-resistant mastitis emphasized the need for early detection and culling of shedders, but the cost-effectiveness of screening every herd quarterly versus only herds with characteriztic clinical signs remains debated. Similarly, the threshold somatic cell count that justifies molecular testing over culture is not standardized across laboratories or regions.

The diagnostic performance of PCR panels is well documented for the major pathogens, with detection limits compatible with clinical use, but the clinical significance of detecting DNA from non-viable organizms is still contested. A positive PCR result does not confirm an active infection, and the distinction matters for treatment decisions.

Referral, Consultation, and Regulatory Reporting

Referral to a diagnostic laboratory is warranted when clinical mastitis fails to respond to therapy, when the herd pattern suggests a contagious pathogen, or when samples repeatedly yield no growth. Laboratories with specialised capacity for mycoplasma culture, antimicrobial resistance surveillance, and molecular typing should be engaged early in a herd outbreak. The USDA Animal and Plant Health Inspection Service provides information on reportable diseases and surveillance programs that may apply in your region.

Regulatory reporting obligations vary by jurisdiction. Some pathogens, including Mycobacterium avium subsp. paratuberculosis, have control programs that require laboratory confirmation and reporting. The World Organization for Animal Health terrestrial standards describe international notification requirements for listed diseases. Consult local authorities before initiating control measures for any pathogen with regulatory implications.

Troubleshooting Guide

Frequently Asked Questions

How Should I Prioritize Diagnostics When the Herd Budget Is Limited?

Start with composite cow-level samples from cows with elevated somatic cell counts or recent clinical episodes. Pooled samples from five to eight cows can reduce culture costs while retaining pathogen detection for common contagious and environmental organizms. Reserve individual quarter samples for recurrent clinical cases or when you suspect Mycoplasma bovis, because pooled samples dilute low shedders. The California Mastitis Test remains a cost-effective screening tool to select cows for culture. When laboratory access is delayed, refrigerate milk samples and submit them within 48 hours. Discuss cost-sharing with the producer by framing culture as an investment that reduces antimicrobial use and culling, not as an optional expense.

What Can I Do When On-Farm Culture or a Diagnostic Laboratory Is Unavailable?

Use the California Mastitis Test and clinical presentation to classify cases into likely Gram-positive, Gram-negative, or culture-negative categories. A cow with acute toxic mastitis and a hot, swollen quarter most likely has an environmental Gram-negative pathogen such as Escherichia coli. A cow with chronic, recurrent, or subclinical mastitis and elevated somatic cell count more likely has a contagious Gram-positive pathogen. Freeze milk samples from severe or recurrent cases for later culture when laboratory access becomes available. Maintain a simple record of clinical severity, affected quarters, and response to therapy. This information supports pattern recognition even without culture confirmation and guides biosecurity decisions.

How Do I Distinguish a True Mycoplasma Outbreak From Other Causes of High Somatic Cell Count?

Mycoplasma bovis mastitis typically presents as sudden, severe, multi-quarter clinical mastitis that fails to respond to conventional antimicrobial therapy. Affected cows often show a marked drop in milk production and a high somatic cell count across multiple quarters. The pathogen does not grow on routine blood agar, so request specific Mycoplasma culture or PCR when you suspect it. Confirm the diagnosis before recommending culling, because the control strategy differs substantially from that for other contagious pathogens. Mycoplasma bovis infection control depends on early detection, strict hygiene, and culling of shedders. Submit samples from at least three affected cows to increase diagnostic sensitivity.

How Should I Record and Present Herd Mastitis Data to the Producer?

Record each clinical case with cow identification, calving date, affected quarters, clinical severity score, culture result, and treatment outcome. Summarize data monthly by pathogen category, lactation stage, and pen. Present the proportion of clinical cases caused by each major pathogen group, the monthly clinical mastitis incidence rate, and the percentage of cows with somatic cell counts above 200,000 cells per mL. Use these metrics to show trends over time and to evaluate whether control measures are working. The USDA APHIS livestock disease resources provide frameworks for surveillance reporting that can be adapted to herd-level monitoring.

Does the Diagnostic Approach Differ for Beef Cows or Small Ruminants?

The principles of aseptic sampling and culture apply across species, but the pathogen spectrum and sampling logistics differ. Beef cows are more often affected by environmental pathogens, and subclinical mastitis is rarely monitored because of infrequent milking. In small ruminants, coagulase-negative staphylococci and Mycoplasma species are more prominent, and the California Mastitis Test is less reliable because of physiological variation in milk composition. Collect individual gland samples instead of composite samples in ewes and does. The FAO animal production guidance offers context on how diagnostic capacity varies across production systems, which influences what is practical in different settings.

How Do I Interpret a Culture Result That Shows No Growth in a Clinically Affected Cow?

No growth occurs in 20 to 30 percent of clinical mastitis cases. Possible explanations include prior antimicrobial therapy, low bacterial shedding, fastidious organizms, or a resolving infection. If the cow is systemically stable, repeat sampling after 48 hours and consider PCR, which can detect non-viable organizms. PCR-based methods can identify major mastitis pathogens directly from milk without the need for bacterial growth. For a cow that remains clinically abnormal, pursue imaging or cytology to rule out abscess formation. Do not assume a negative culture means the infection has cleared. Recheck the cow clinically and by somatic cell count before drying off.

Related Clinical & Scientific Guides

• Rumen Health Assessment in Dairy Cows: Clinical and Subclinical Indicators
• Mastitis Control Programs in Dairy Herds: Monitoring and Prevention
• Swine Nutrition and Health: Feed-Related Disease Diagnosis

References and Further Reading

• Advances in therapeutic and managemental approaches of bovine mastitis: a comprehensive review.. 2021.
• <i>Escherichia coli</i> Mastitis in Dairy Cattle: Etiology, Diagnosis, and Treatment Challenges.. 2022.
• Mycoplasma bovis as an agent of mastitis, pneumonia, arthritis and genital disorders in cattle.. 1996.
• Johne's disease in Canada part II: disease impacts, risk factors, and control programs for dairy producers.. 2006.
• Development of a rapid and sensitive test for identification of major pathogens in bovine mastitis by PCR.. 2001.
• Causes, types, etiological agents, prevalence, diagnosis, treatment, prevention, effects on human health and future aspects of bovine mastitis.. 2020.
• USDA APHIS Animal Health Information. USDA APHIS.
• FAO Animal Production and Health. FAO.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Diagnostic Approach to Weight Loss in Adult Dairy Cows: Parasitism, Nutrition, and Chronic Disease
• Dairy Calf Health: Diagnostic Approach to Neonatal Diarrhea
• Dairy Cow Nutrition: Diagnostic Approach to Metabolic Disorders
• Dairy Herd Reproductive Efficiency: Metrics and Diagnostic Investigation
• Diagnostic Approach to Lameness in Dairy Cattle: Lesion Localization

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.